| 000 | 00947 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517130500.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2016-10-743930 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParker, William A E | |
| 245 | 0 | 0 |
_aTicagrelor: agonising over its mechanisms of action. _h[electronic resource] |
| 260 |
_bBlood _c12 2016 |
||
| 300 |
_a2595-2597 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
| 650 | 0 | 4 | _aPurinergic P2Y Receptor Antagonists |
| 650 | 0 | 4 | _aTicagrelor |
| 700 | 1 | _aStorey, Robert F | |
| 773 | 0 |
_tBlood _gvol. 128 _gno. 23 _gp. 2595-2597 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2016-10-743930 _zAvailable from publisher's website |
| 999 |
_c26679107 _d26679107 |
||